1. GLUT1, LDHA, and MCT4 Expression Is Deregulated in Cervical Cancer and Precursor Lesions
- Author
-
Ma. A. Reyna-Hernández, Luz del C. Alarcón-Romero, Julio Ortiz-Ortiz, Berenice Illades-Aguiar, Marco A. Jiménez-López, Azucena Ocampo-Bárcenas, Martin O. Morrugares-Ixtepan, and Francisco I. Torres-Rojas
- Subjects
Monocarboxylic Acid Transporters ,Glucose Transporter Type 1 ,Histology ,L-Lactate Dehydrogenase ,Papillomavirus Infections ,Glucose Transport Proteins, Facilitative ,Muscle Proteins ,Uterine Cervical Neoplasms ,Articles ,Uterine Cervical Dysplasia ,Humans ,Female ,Lactate Dehydrogenase 5 ,Anatomy - Abstract
Metabolic reprogramming is typical in cancerous cells and is required for proliferation and cellular survival. In addition, oncoproteins of high-risk human papillomavirus (HR-HPV) are involved in this process. This study evaluated the relationship between glucose transporter I (GLUT1), lactate dehydrogenase A (LDHA), and monocarboxylate transporter type 4 (MCT4) expression and cervical intraepithelial neoplasia (CIN) and invasive cervical carcinoma (ICC) with HR-HPV infection. The protein expression was evaluated in women with CIN I ( n=20), CIN II/III ( n=16), or ICC ( n=24) by immunohistochemistry. The protein expression was analyzed qualitatively by van Zummeren score and quantitatively by Image ProPlus 6 software. LDHA expression increases in HPV-16 infection. In the CIN I group, GLUT1 immunostaining has a 35% protein expression at the membrane level at more than two thirds of the epithelium, which increased by 21.25% more in CIN II/III in more than two thirds of the epithelium. While LDHA and MCT4 in CIN I mostly do not present immunostaining, or this was only limited to the basal stratum, this expression is increased in CIN II/III and ICC cases. The GLUT1, LDHA, and MCT4 expression increased in ICC. The overexpression in high-grade CIN with HR-HPV infection shows a higher risk for cervical carcinoma progression.
- Published
- 2022
- Full Text
- View/download PDF